Trade Mark Journal No.2026/002 9 January 2026

WO0000001892219 (5,42)

Office of origin: United States of America

Date of International Registration:17 November 2025
Date of designation in the UK: 17 November 2025
Image for mark 1892219 CORETERRA THERAPEUTICS

Class 5
Pharmaceutical preparations for the treatment of neuropsychiatric conditions, namely, autism spectrum disorder and its symptoms.
Class 42
Pharmaceutical research in the field of treatments for neuropsychiatric conditions, namely, autism spectrum disorder and its symptoms.

Coreterra Therapeutics, Inc.

Representative: Lynn E. Rzonca Ballard Spahr LLP, 1735 Market Street, 51st Floor, Philadelphia PA 19103, UNITED STATES OF AMERICA